Photochemistry and Photobiology, 2015, 91 787
Aldrich) were used as a mobile phase for LC-MS/MS. The LC-grade
water (below 1 [lS cmÀ1]) was prepared by reverse osmosis in a Demi-
wa 5ROI system from Watek (Ledec and Sazavou, Czech Republic), fol-
lowed by double distillation from a quartz apparatus. Only freshly
distilled water was used.
CH2); 0.88 (t., 3H, CH3); 13C NMR (100 MHz; CDCl3) d (ppm): 165.6;
151.7; 148.0; 147.9; 134.9; 130.5; 123.2; 40.1; 31.7; 29.5–29.9; 22.5;
13.9.
N-(3-pyridine)tridecanoylamide was obtained by a Beckmann rear-
rangement reaction catalyzed by thionyl chloride (30). According to the
reaction’s procedure, a mixture containing chloroform, (E)-oxime of 1-(3-
pyridyl)tridecan-1-one and thionyl chloride was boiled under reflux for
6 h. The liquid obtained after evaporation of chloroform was dissolved in
ethanol and the solution was made alkaline with NaOH. Filtration and
evaporation of ethanol gave N-(3-pyridyl)tridecanoylamide as white crys-
tals (10% yield; m.p. 173.6–174.9°C; 1H NMR (400 MHz; CDCl3), d
(ppm): 9.70 (br., s., 1H, NH), 9.01 (d.,1H, Hpy(2), J = 2.3 Hz) 8.39
(d.d., 1H, Hpy(6), J = 4.7 and 1.6 Hz), 8.28 (d.d.d.,1H, Hpy(4), J = 2.3,
8.2 and 1.6 Hz), 7.47 (t.d, 1H, Hpy(5), J = 8.2 and 4.7 Hz), 1.68 (t., 2H,
CH2-CO), 1.28–1.22 (m., 20H, CH2), 0.87 (t., 3H, CH3); 13C (100 MHz;
CDCl3) d (ppm): 156.5; 139.9; 138.2; 136.9; 132.2; 130.1; 36.1; 32.0;
29.7–25.5; 22.7; 13.9. GC-TOFMS (60 eV) m/z (%): 289 (8.7); 195
(7.1); 153 (8.3); 136 (38.1); 94 (100); 43 (12).
Synthesis of pyridinektoximes. The (E) and (Z)-oxime of 1-(2-pyridyl)
tridecan-1-one and 1-(3-pyridyl)tridecan-1-one were synthesized in the
two-stage process (7,10,25,26): the synthesis of pyridineketones from
pyridinecarbonitryle and alkyl magnesium bromide in diethyl ether as dil-
uent and the oximation reaction of the alkyl-pyridyl ketones by hydroxyl-
amine hydrochloride in ethanol solutions in the presence of Na2CO3 (pH
6–7). 1H and 13C NMR were used to prove the structure of the synthe-
sized oximes (yields: 1-(2-pyridyl)tridecan-1-one oxime – 42%, 1-(3-pyr-
idyl)tridecan-1-one oxime – 68%; purity 99.8%). Oxime of 1-(2-pyridyl)
tridecan-1-one was mainly obtained as a (Z)-stereoisomer and the separa-
tion of (E) from (Z)-stereoisomer (mol fraction 0.01: 0.99) was performed
according to procedure described by Cibulka et al. (27). Oxime of 1-(3-
pyridyl)tridecan-1-one also contained both (Z)- and (E)-stereoisomer (mol
fraction 0.09: 0.91), but the isolation of the isomers was possible by dis-
solution of (E)-isomer of 1-(3-pyridyl)tridecan-1-one oxime in isooctane.
The (Z)-isomer remained as a precipitate and after recrystalization from a
minimum quantity of hot ethanol yielded the (Z)-oxime of 1-(3-pyridyl)
tridecan-1-one.
3-aminopyridine and tridecanoic acids were also observed as the by-
products of the Beckmann rearrangement (3% yield).
3-aminopyridine (31): 1H NMR (400 MHz; CDCl3), d (ppm): 8.05 (s,
1H, Hpyr(2)), 8.01 (d, 1H, Hpyr(6), J = 7.5 Hz), 7.09 (d.d.,2H, Hpyr(5),
J = 6.8 and 7.2 Hz), 6.95 (d., 2H, Hpyr(4), J = 7.0 Hz), 3.71 (br., s., 2H,
N-H); 13C NMR (100 MHz CDCl3) d (ppm): 143.1, 140.1 137.0, 122.9,
121.7.
(E)-oxime of 1-(2-pyridyl)tridecan-1-one: m.p. 61.6–63.1°C (27); 1H
NMR (400 MHz; CDCl3) d(ppm): 8.36 (s., 1H, OH); 8.68 (d, 1H,
Hpy(6), J = 4.2 Hz); 7.78 (d, 1H, Hpy(3), J = 7.9 Hz); 7.72 (t.d., 1H,
Hpy(4), J = 7.5 and 1.7 Hz)); 7.21 (m., 1H, Hpy(5)); 3.28 (t., 2H, CH2);
1.58 (q, 2H, CH2); 1.27–1.29 (m, 18H, CH2); 0.91 (t, 3H, CH3); 13C
Tridecanoic acid m.p. 34.2–36.6°C (CAS No.: 638-53-9); 1H NMR
(400 MHz; CDCl3), d (ppm): 10.98 (br. s.,1H, O-H); 2.34 (t., 2H, CH2);
1.65 (q., 2H, CH2); 1.28–1.22 (m., 18H, CH2); 0.87 (t., 3H, CH3); 13C
NMR (100 MHz; CDCl3) d (ppm): 180.8; 34.3; 32.0; 29.7–29.2; 25.2;
22.8; 13.9.
NMR (100 MHz; CDCl3)
d (ppm): 160.6; 154.0; 149.0; 136.3;
123.4; 120.9; 30.7; 29.3; 29.2; 29.7; 29.8; 29.9; 29.9; 29.9; 29.7; 31.9;
22.7; 14.1
The Beckmann rearrangement reaction catalyzed by thionyl chloride
was also applied to a synthesis of N-(2-pyridyl)tridecanoylamide, but the
expected product degraded immediately to 2-aminopyridine and trideca-
noic acid.
(Z)-oxime of 1-(2-pyridyl)tridecan-1-one: m.p. 56.1–57.4°C (27); 1H
NMR (400 MHz; CDCl3) d(ppm): 9.53 (s., 1H, OH); 8.67 (d.d, 1H,
Hpy(6), J = 4.8 and 1.8 Hz); 7.85 (t, 1H, Hpy(3), J = 7.6 Hz); 7.69 (t.d.,
1H, Hpy(4), J = 7.7 and 1.5 Hz)); 7.35 (d.d., 1H, Hpy(5), J = 4.8 and
7.4 Hz); 3.03 (t., 2H, CH2); 1.62 (q, 2H, CH2); 1.27–1.29 (m, 18H,
CH2); 0.91 (t, 3H, CH3); 13C NMR (100 MHz; CDCl3) d (ppm): 154.0;
160.7; 149.0; 136.3; 123.5; 120.9; 31.9; 29.4; 29.3; 29.7; 29.9; 29.9;
29.9; 29.9; 29.7; 31.9; 22.7; 14.1
2-aminopyridine (31): 1H NMR (400 MHz; CDCl3) d (ppm): 8.11 (d.,
1H, Hpyr(2), J = 4.4 Hz); 7.45 (t., 1H, Hpyr(4), J = 7.0 Hz); 6.66 (t., 1H,
Hpyr(5)), 6.44 (d., 1H, Hpyr(3) J = 7.4 Hz); 4.62 (br. s., 2H, N-H); 13C
NMR (100 MHz; CDCl3), d (ppm): 159.1; 147.8; 138.4; 114.9; 109.2.
Photostability studies of oximes. 1-(2-pyridyl)tridecan-1-one oxime
and 1-(3-pyridyl)tridecan-1-one oxime dissolved in toluene or heptane
(E)-oxime of 1-(3-pyridyl)tridecan-1-one: m.p. 73.5–75.1°C; 1H NMR
(400 MHz; CDCl3) d(ppm): 10.6 (br. s, 1H, OH); 8.6 (d.d., 1H, Hpy(6),
J = 1.4 and 4.9 Hz); 7.93 (d.d.d., 1H, Hpy(4), J = 2.6; 1.8 and 1.0 Hz);
7.32 (d.d.,1H, Hpy(5), J = 5.1 and 2.0 Hz); 8.9 (d., 1H, Hpy(2)
J = 2.2 Hz,); 2.71 (t., 2H, CH2); 1.54 (q., 2H, CH2); 1.31–1.24 (m.,
18H, CH2); 0.86 (t., 3H, CH3); 13C NMR (100 MHz; CDCl3) d(ppm):
147.2; 132.2; 133.7; 149.3; 122.9; 157.0; 32.8; 31.6; 29.8; 29.6; 29.3;
29.1; 26.2; 25.6; 22.5; 14.0.
and their complexes with copper(II) chloride (1 9 10À3 mol oxime LÀ1
)
dissolved in toluene were irradiated in a Heraeus photoreactor of 120 mL
volume containing a medium pressure mercury lamp TQ 150 W (Herae-
us) and quartz filter (1 mL optical length) (32–35). The lamp was posi-
tioned within the inner part of the photoreactor, and cooling water was
circulated through a Pyrex jacket surrounding the tube. Argon was passed
through the solutions with a stationary flow of 2 mL minÀ1 at 22–23°C
during the irradiation. Agitation of the reaction mixture was provided by
a magnetic stirrer. The photodegradation was repeated two times with a
standard deviation = 5–8%. The photon fluence of the mercury lamp was
determined by chemical actinometry using uridine (254 nm) and potas-
sium ferrioxalate (366 nm), and the lamp radiated the reaction solution
with the intensity of 0.064 9 10À3 einstein LÀ1 minÀ1 at 254 nm and
0.071 9 10À3 einstein/(Lmin) at 366 nm. The samples were collected at
1, 2, 5, 10, 15, 30, 60, 120, 180, 240, 300, 360, 420, 480, 540 and
600 min of UV-Vis exposure. Analyses were performed using the follow-
ing techniques: NMR (1H, 13C), UV-VIS spectroscopy, LC-MS/MS and
GC-TOFMS.
(Z)-oxime of 1-(3-pyridyl)tridecan-1-one: m.p. 103.1–104.7°C; 1H
NMR (400 MHz; CDCl3) d (ppm): 10.7 (br. S.,1H, OH); 8.56 (dd, 1H,
Hpy(6), J = 1.4 and 4.9 Hz); 7.91 (d.d.d., 1H, Hpy(4), J = 2.6; 1.8 and
1.0 Hz); 7.36 (d.d.,1H, Hpy(5), J = 5.0 and 1.9 Hz); 8.72 (d, 1H, Hpy(2)
J = 2.2 Hz,); 2.68 (t, 2H, CH2); 1.54 (q, 2H, CH2); 1.31–1.24 (m, 18H,
CH2); 0.86 (t,3H, CH3); 13C NMR (100 MHz; CDCl3) d (ppm): 157.0;
149.3; 147.2; 133.7; 132.2; 122.9; 32.8; 31.6; 29.8; 29.6; 29.3; 29.1;
26.2; 25.6; 22.5; 14.0.
Synthesis of Beckmann rearrangement products. N-dodecylpyridine-2-
carboxamide and N-dodecylpyridine-3-carboxamide were obtained in a
direct reaction of dodecylamine with picolinic or nicotinic acid, respec-
tively (28,29). The mixtures were heated to reflux (200–215°C) for 12 h,
cooled and extracted with diethyl ether. The extracts were washed with
5% NaHCO3, brine and water. After the solvent removal the amides were
crystalized from an ethanol–water solution.
Isolation of photoproducts. Photosubstitution products were identified
by NMR (1H and 13C) and their structures were elucidated after isolation
by TLC or on a silica column using a mixture of ethyl acetate and di-
chloromethane as a developing solvent.
N-dodecylpyridine-2-carboxamide (28): m.p. 47.1–48.4°C; 1H NMR
(400 MHz; CDCl3) d(ppm): 8.54 (d.d., 1H, Hpy(6), J = 1.7 and 4.6 Hz),
8.21 (d., 1H, Hpy(3), J = 2.4 Hz), 8.06 (s., 1H, NH); 7.85 (t.d.d., 1H,
Hpy(4); J = 2.4, 7.9 and 1.7 Hz); 7.42 (t.d., 1H, Hpy(5); J = 7.9 and
4.6 Hz); 3.47 (q., 2H, -CH2-N); 1.30–1.26 (m., 20H, CH2); 0.88 (t., 3H,
CH3); 13C NMR (100 MHz; CDCl3) d (ppm): 164.3; 150.3; 147.9;
137.4; 126.2; 122.1; 42.1; 31.7; 29.5–29.9; 22.5; 13.9.
1-(6-heptylpyridin-2-yl)tridecan-1-one oxime; 1H NMR (400 MHz;
CDCl3), d (ppm): 9.67 (s., 1H, OH); 7.45 (d, 1H, Hpy(3)); 7.69 (d., 1H,
Hpy(4)); 7.35 (d., 1H, Hpy(5),); 3.20 (t., 2H, CH2); 2.60 (t., 2H, CH2);
1.58–1.62 (q, 4H, CH2); 1.26–1.30 (m, 26H, CH2); 0.89–0.92 (t, 6H,
CH3); 13C NMR (100 MHz; CDCl3) d (ppm): 157.4; 157.1; 153.5;
138.8; 123.0; 118.5; 34.5; 31.3, 32.0; 29.2; 29.1; 29.7; 29.9; 29.9; 29.9;
29.8; 29.5; 31.8; 22.6; 14.0; MS (ESI) (m/z ratio) 389.4 (MH)+.
1-(6-benzylpyridin-2-yl)tridecan-1-one oxime; 1H NMR (400 MHz;
CDCl3), d (ppm): 13C (100 MHz; CDCl3) d (ppm): 9.67 (s., 1H, OH);
7.45 (d, 1H, Hpy(3)); 7.69 (d., 1H, Hpy(4)); 7.35 (d., 1H, Hpy(5),); 7.31
(t., 2H, Hb(3)); 7.20 (t., 1H, Hb(4)); 7.13 (d., 2H, Hb(2)); 4.17 (s., 2H,
CH2); 2.93 (t., 2H, CH2); 1.62 (q, 2H, CH2); 1.27–1.29 (m, 18H, CH2);
N-dodecylpyridine-3-carboxamide (29): m.p. 76.8–78.1°C; 1H NMR
(400 MHz; CDCl3) d (ppm): 8.89 (d.d.,1H, Hpy(2), J = 2.2 and 0.7 Hz);
8.63 (d.d., 1H, Hpy(6), J = 4.8 and 1.6 Hz); 8.05 (d.d.d.,1H, Hpy(4),
J = 2.2, 8.0 and 1.6 Hz); 7.30 (t.d.d, 1H, Hpy(5), J = 0.7, 8.0 and
4.8 Hz); 6.31 (s., 1H, NH); 3.45 (t., 2H, CH2-N); 1.28–1.26 (m., 20H,